TP53 and cancer: Consistent with other p53-deficient cancer models, all SCLC tumor-derived cell lines had high levels of the p19Arf tumor suppressor, a negative regulator of the p53-targeting ubiquitin ligase, Mdm2 (Supplementary Fig. 2e)27.